Aranesp
(darbepoetin alfa)
Treats anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

View DetailsVisit Website
Enbrel
(etanercept)
Treats moderate to severe rheumatoid arthritis, adult chronic moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and moderate to severe juvenile idiopathic arthritis.

View DetailsVisit Website
EPOGEN
(epoetin alfa)
Treats a lower than normal number of red blood cells (anemia) caused by chronic kidney failure in patients on dialysis.

View DetailsVisit Website
Neulasta
(pegfilgrastim)
Reduces the risk of infection (intially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.

View DetailsVisit Website
NEUPOGEN
(filgrastim)
Treats neutropenia (a low number of neutrophils), stimulating the bone marrow to increase production of neutrophils.

View DetailsVisit Website
Nplate
(romiplostim)
Treats anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis.

View DetailsVisit Website
Prolla
(denosumab)
Treats moderate to severe rheumatoid arthritis, adult chronic moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and moderate to severe juvenile idiopathic arthritis.

View DetailsVisit Website
Sensipar
(cinacalcet)
Treats a lower than normal number of red blood cells (anemia) caused by chronic kidney failure in patients on dialysis.

View DetailsVisit Website
Vectibix
(panitumumab)
Reduces the risk of infection (intially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.

View DetailsVisit Website
XGEVA
(denosumba)
Treats neutropenia (a low number of neutrophils), stimulating the bone marrow to increase production of neutrophils.

View DetailsVisit Website